116 related articles for article (PubMed ID: 29464064)
1. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.
Karnevi E; Dror LB; Mardinoglu A; Elebro J; Heby M; Olofsson SE; Nodin B; Eberhard J; Gallagher W; Uhlén M; Jirström K
Oncotarget; 2018 Jan; 9(5):6188-6200. PubMed ID: 29464064
[TBL] [Abstract][Full Text] [Related]
2. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
Olsson Hau S; Wahlin S; Cervin S; Falk V; Nodin B; Elebro J; Eberhard J; Moran B; Gallagher WM; Karnevi E; Jirström K
J Pathol Clin Res; 2022 Jan; 8(1):65-77. PubMed ID: 34379360
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
4. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
Biomark Res; 2014; 2():11. PubMed ID: 24963396
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
Heby M; Elebro J; Nodin B; Jirström K; Eberhard J
BMC Clin Pathol; 2015; 15():10. PubMed ID: 26028992
[TBL] [Abstract][Full Text] [Related]
6. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
[TBL] [Abstract][Full Text] [Related]
7. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.
Grupp K; Wilking J; Prien K; Hube-Magg C; Sirma H; Simon R; Steurer S; Budäus L; Haese A; Izbicki J; Sauter G; Minner S; Schlomm T; Tsourlakis MC
Eur J Cancer; 2014 Mar; 50(4):852-61. PubMed ID: 24380696
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis.
Fristedt R; Elebro J; Gaber A; Jonsson L; Heby M; Yudina Y; Nodin B; Uhlén M; Eberhard J; Jirström K
PLoS One; 2014; 9(11):e112728. PubMed ID: 25397670
[TBL] [Abstract][Full Text] [Related]
9. Expression of RNA-binding Motif Protein 3 (
Jang HH; Lee HN; Kim SY; Hong S; Lee WS
Anticancer Res; 2017 Apr; 37(4):1779-1785. PubMed ID: 28373441
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
Biomark Res; 2017; 5():10. PubMed ID: 28293425
[TBL] [Abstract][Full Text] [Related]
11. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J
PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641
[TBL] [Abstract][Full Text] [Related]
12. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer.
Hjelm B; Brennan DJ; Zendehrokh N; Eberhard J; Nodin B; Gaber A; Pontén F; Johannesson H; Smaragdi K; Frantz C; Hober S; Johnson LB; Påhlman S; Jirström K; Uhlen M
Proteomics Clin Appl; 2011 Dec; 5(11-12):624-35. PubMed ID: 21956899
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer.
van der Zee JA; van Eijck CH; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; Ten Hagen TL
Eur J Surg Oncol; 2012 Nov; 38(11):1058-64. PubMed ID: 22633450
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study.
Florianova L; Xu B; Traboulsi S; Elmansi H; Tanguay S; Aprikian A; Kassouf W; Brimo F
World J Surg Oncol; 2015 Nov; 13():317. PubMed ID: 26577765
[TBL] [Abstract][Full Text] [Related]
15. RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.
Ehlén Å; Nodin B; Rexhepaj E; Brändstedt J; Uhlén M; Alvarado-Kristensson M; Pontén F; Brennan DJ; Jirström K
Transl Oncol; 2011 Aug; 4(4):212-21. PubMed ID: 21804916
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding proteins RBM-HuR, RBM3 and PODXL expression in urothelial carcinoma of the urinary bladder. Prognostic and clinical implications.
Hafez AM; Seleem MM; Alattar AZ; Elshorbagy S; Elsayed WSH
Contemp Oncol (Pozn); 2021; 25(4):279-290. PubMed ID: 35079236
[TBL] [Abstract][Full Text] [Related]
17. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
18. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
20. High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.
Kang SH; Cho J; Jeong H; Kwon SY
J Breast Cancer; 2018 Sep; 21(3):288-296. PubMed ID: 30275857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]